Billets de Michelle Dawson

Billet publié sur Bluesky le 03/06/2024 11:25

Bluesky Publication avec DOI crossref Extrait cité dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Anna Baldes, Tamara May, Amanda Brignell, Katrina Williams (2026). Patterns of Psychotropic Prescribing Practices in Autistic Children and Adolescents: An Australian Perspective of Two Cohorts Five Years Apart. Child Psychiatry & Human Development, 57(2), 428-442. Springer Science and Business Media LLC.

Date de publication
01/06/2024
Identifiant
10.1007/s10578-024-01710-5
Auteurs
Anna Baldes, Tamara May, Amanda Brignell, Katrina Williams
Source
Child Psychiatry & Human Development
Détails
57(2), 428-442
Type de référence
article
Éditeur
Springer Science and Business Media LLC
Source de métadonnées
crossref

Résumé

Abstract This study aims to describe the utilisation of psychotropic medications in Australian autistic children and adolescents. All children and adolescents with available Pharmaceutical Benefits Scheme data who endorsed an autism diagnosis in The Longitudinal Study of Australian Children, including both B (n = 233, age 0–1 years in wave 1) and K cohorts (n = 157, age 4–5 years in wave 1), were included to describe psychotropic prescribing patterns. 212 (54.4%) autistic children and adolescents received at least one psychotropic prescription and 99 (25.4%) had polypharmacy. The most common psychotropic class prescribed was antidepressants (31.3%). Children in the B cohort were more likely to have a parent-reported diagnosis of anxiety or depression (χ 2 = 12.18, p < 0.001) and tended to be more likely to have received a psychotropic prescription (χ 2 = 3.54, p = 0.06). Psychotropic prescribing in Australian autistic children is common despite limited evidence for efficacy and tolerability of psychotropics in this group.

Auteur·ices de l’étude dans cette référence citée